1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Serrano-Villar S, López-Huertas MR, Jiménez D, Galera C, Martínez-Sanz J, Moreno E, Muriel A, Gutiérrez F, Busca C, Portilla J, Bisbal O, Iribarren JA, Tejerina F, de Los Santos I, Moreno S.

    Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.

    Frontiers in immunology . 13: 848630-848630. Nº de citas: 3

    [doi:10.3389/fimmu.2022.848630]

  • Manzano M, Talavera-Rodríguez A, Moreno E, Madrid N, Gosalbes MJ, Ron R, Dronda F, Pérez-Molina JA, Lanza VF, Díaz J, Moreno S, Navia B, Serrano-Villar S.

    Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV.

    Nutrients . 14(6): . Nº de citas: 1

    [doi:10.3390/nu14061221]

  • Albóniga OE, Jiménez D, Sánchez-Conde M, Vizcarra P, Ron R, Herrera S, Martínez-Sanz J, Moreno E, Moreno S, Barbas C, Serrano-Villar S.

    Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.

    JOURNAL OF PROTEOME RESEARCH . 21(3): 623-634. Nº de citas: 1

    [doi:10.1021/acs.jproteome.1c00786]

  • Sainz T, Diaz L, Rojo D, Clemente MI, Barbas C, Gosalbes MJ, Jimenez-Hernandez N, Escosa L, Guillen S, Ramos JT, Muñoz-Fernández MÁ, Navarro ML, Mellado MJ, Serrano-Villar S.

    Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial

    Nutrients . 14(5): . Nº de citas: 6

    [doi:10.3390/nu14050992]

  • Podzamczer D, Micán R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, Ribera E, Vivancos MJ, Morano L, Masiá M, Gómez C, Fanjul F, Payeras A, Inciarte A, Estrada V, Rivero A, Castro Á, Bernal E, Vinuesa D, Knobel H, Troya J, Macías J, Montero M, Sanz J, Navarro-Alcaraz A, Caicedo A, Fernández G, Martínez E, Moreno S.

    Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

    Open forum infectious diseases . 9(3): .

    [doi:10.1093/ofid/ofab595]

  • Balandín B, Ballesteros D, Pintado V, Soriano-Cuesta C, Cid-Tovar I, Sancho-González M, Pérez-Pedrero MJ, Chicot M, Asensio-Martín MJ, Silva JA, de Luna RR, Gesso CM, Rodríguez-Serrano DA, Martínez-Sagasti F, Royuela A.

    Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . 59(3): 106536-106536. Nº de citas: 10

    [doi:10.1016/j.ijantimicag.2022.106536]

  • Sherrill-Mix S, Yang M, Aldrovandi GM, Brenchley JM, Bushman FD, Collman RG, Dandekar S, Klatt NR, Lagenaur LA, Landay AL, Paredes R, Tachedjian G, Turpin JA, Serrano-Villar S, Lozupone CA, Ghosh M.

    A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 38(3): 173-180.

    [doi:10.1089/aid.2021.0173]

  • Fursa O, Mocroft A, Lazarus JV, Amele S, Lundgren J, Matulionyte R, Rasmussen LD, Rockstroh JK, Parczewski M, Jilich D, Moreno S, Vassilenko A, Lacombe K, Wandeler G, Borodulina E, Brännström J, Wiese L, Orkin C, Behrens GMN, Mansinho K, Portu JJ, Peters L, EuroSIDA study.

    The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

    AIDS . 36(3): 423-435. Nº de citas: 9

    [doi:10.1097/QAD.0000000000003112]

  • Vallejo A, Martín-Hondarza A, Gómez S, Velasco H, Vizcarra P, Haemmerle J, Casado JL.

    Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

    FRONTIERS IN MICROBIOLOGY . 12: 812729-812729. Nº de citas: 5

    [doi:10.3389/fmicb.2021.812729]

  • Ruiz-Galiana, Julian, de Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Hernandez-Sampelayo, Teresa, Cruz Martin-Delgado, Mari, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Canton, Rafael, Bouza, Emilio.

    Persistence and viability of SARS-CoV-2 in primary infection and reinfections

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(1): 1-6. Nº de citas: 3

    [doi:10.37201/req/129.2021]

  • de Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Hernandez-Sampelayo, Teresa, Cruz Martin-Delgado, Mari, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Ruiz-Galiana, Julian, Canton, Rafael, Bouza, Emilio.

    Actions and attitudes on the immunized patients against SARS-CoV-2

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(1): 7-15. Nº de citas: 1

    [doi:10.37201/req/131.2021]

  • Del Amo J, Polo R, Moreno S, Jarrín I, Hernán MA.

    SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment

    AIDS . 36(2): 161-168. Nº de citas: 17

    [doi:10.1097/QAD.0000000000003132]

  • Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J, REIPI-GEIRAS-FOREST group.

    Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.

    Jama Network Open . 5(1): . Nº de citas: 8

    [doi:10.1001/jamanetworkopen.2021.37277]

  • Pintado V, Ruiz-Garbajosa P, Escudero R, Gioia F, Herrera S, Vizcarra P, Fortún J, Cobo J, Martín-Dávila P, Morosini MI, Cantón R, Moreno S.

    Carbapenemase-producing Enterobacterales infections in COVID-19 patients

    INFECTIOUS DISEASES . 54(1): 36-45. Nº de citas: 8

    [doi:10.1080/23744235.2021.1963471]

  • Gosalbes MJ, Jimenéz-Hernandéz N, Moreno E, Artacho A, Pons X, Ruíz-Pérez S, Navia B, Estrada V, Manzano M, Talavera-Rodriguez A, Madrid N, Vallejo A, Luna L, Pérez-Molina JA, Moreno S, Serrano-Villar S.

    Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV.

    Gut Microbes . 14(1): 2089002-2089002. Nº de citas: 2

    [doi:10.1080/19490976.2022.2089002]

  • Brañas F, Galindo MJ, Torralba M, Antela A, Vergas J, Ramírez M, Ryan P, Dronda F, Busca C, Machuca I, Bustinduy MJ, Cabello A, Sánchez-Conde M.

    Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

    Plos One . 17(3): . Nº de citas: 3

    [doi:10.1371/journal.pone.0266191]

  • Bravo-Gallego LY, Francisco-González L, Vázquez-Pérez Á, García-López Hortelano M, López Vélez R, González-Granado LI, Santos M, Epalza C, Jiménez AB, Cilleruelo MJ, Guillén S, Fernández T, Olabarrieta I, Flores-Chavez M, Ramos Amador JT, González-Tomé MI.

    Pediatric Chagas disease in the non-endemic area of Madrid: A fifteen-year review (2004-2018).

    PLOS NEGLECTED TROPICAL DISEASES . 16(2): 10232-10232. Nº de citas: 1

    [doi:10.1371/journal.pntd.0010232]

  • Casado JL, Moraga E, Vizcarra P, Velasco H, Martín-Hondarza A, Haemmerle J, Gómez S, Quereda C, Vallejo A.

    Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients

    VIRUSES-BASEL . 14(1): . Nº de citas: 10

    [doi:10.3390/v14010046]